Arch Venture Fund Ix Overage, L.p. - Net Worth and Insider Trading

Over the past 18 months, Arch Venture Fund Ix Overage, L.p. made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 114,771 shares made by Terry-ann Burrell , a net sale of 17,788 shares made by Christine Bellon , and a net sale of 215,751 shares made by Giuseppe Ciaramella .

In summary, during the past 3 months, insiders sold 1,016,735 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 1,016,735 shares. During the past 18 months, 1,383,256 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,383,256 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Ix Overage, L.p. made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 5,402,239 shares made by Svf Endurance (cayman) Ltd , a net sale of 107,595 shares made by Vicki L Sato , and a net sale of 58,569 shares made by Phillip Pang .

In summary, during the past 3 months, insiders sold 167,399 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 167,399 shares. During the past 18 months, 5,794,272 shares of Vir Biotechnology Inc (VIR) were sold and 7,500 shares were bought by its insiders, resulting in a net sale of 5,786,772 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Ix Overage, L.p. made no insider transaction in Karuna Therapeutics Inc (KRTX). Other recent insider transactions involving Karuna Therapeutics Inc (KRTX) include a net sale of 85,000 shares made by Stephen K. Brannan , a net sale of 34,017 shares made by Troy A. Ignelzi , and a net sale of 75,000 shares made by Andrew Craig Miller .

In summary, during the past 3 months, insiders sold 10,000 shares of Karuna Therapeutics Inc (KRTX) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 242,473 shares of Karuna Therapeutics Inc (KRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 242,473 shares.

Karuna Therapeutics Inc (KRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Ix Overage, L.p. made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 298,570 shares made by Bryan Giraudo , a net sale of 13,395 shares made by Richard Aranda , and a net purchase of 855,400 shares made by Faheem Hasnain .

In summary, during the past 3 months, insiders sold 44,068 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 44,068 shares. During the past 18 months, 67,038 shares of Gossamer Bio Inc (GOSS) were sold and 1,234,072 shares were bought by its insiders, resulting in a net purchase of 1,167,034 shares.

Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Ix Overage, L.p. made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net sale of 949,000 shares made by Flagship Ventures Fund V, L.p. , a net purchase of 1,818,181 shares made by Keith Crandell , and a net purchase of 1,818,181 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 25,000 shares of Sana Biotechnology Inc (SANA) in total and bought 5,454,543 shares, with a net purchase of 5,429,543 shares. During the past 18 months, 1,049,000 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,405,543 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Ix Overage, L.p. made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net sale of 58,020 shares made by Richard Klausner ,

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,020 shares of Lyell Immunopharma Inc (LYEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 58,020 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.